Drugs / MDMA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01689740 | Jan 2013 → Apr 2016 | post-traumatic stress disorder | Resilient Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDMA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01689740 ↗ |
| Route | Oral | “administered orally” NCT01689740 ↗ |